scispace - formally typeset
Y

Yuen-Joyce Liu

Researcher at Harvard University

Publications -  12
Citations -  1392

Yuen-Joyce Liu is an academic researcher from Harvard University. The author has contributed to research in topics: Medicine & CD74. The author has an hindex of 8, co-authored 8 publications receiving 1260 citations.

Papers
More filters
Journal ArticleDOI

Nod2 is required for the regulation of commensal microbiota in the intestine

TL;DR: It is shown that Nod2 plays an essential role in controlling commensal bacterial flora in the intestine by regulating each other through a feedback mechanism, and Dysfunction of Nod1 results in a break-down of this homeostasis.
Journal ArticleDOI

NLR family member NLRC5 is a transcriptional regulator of MHC class I genes

TL;DR: NLRC5 is identified as a transcriptional regulator, orchestrating the concerted expression of critical components in the MHC class I pathway, and induced the expression of β2-microglobulin, transporter associated with antigen processing, and large multifunctional protease, which are essential for M HC class I antigen presentation.
Journal ArticleDOI

Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum

TL;DR: Nod2-deficient mice inoculated with Helicobacter hepaticus developed granulomatous inflammation of the ileum, characterized by an increased expression of Th1-related genes and inflammatory cytokines, which may provide insight into Nod2 function relevant to inflammation of ileal Crohn’s disease.
Journal ArticleDOI

NLRC5 Cooperates with the RFX Transcription Factor Complex To Induce MHC Class I Gene Expression

TL;DR: It is shown that NLRC5-mediated MHC class I gene induction requires the W/S and X1, X2 cis-regulatory elements and can cooperate with ATF1 and the transcriptional coactivators CBP/p300 and general control nonderepressible 5, which display histone acetyltransferase activity.
Journal ArticleDOI

Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy.

TL;DR: The structural modifications of MDP and its derivatives have been extensively studied in an attempt to increase adjuvant activity and boost the immune response effectively for clinical use in the treatment of cancer and other diseases.